Comparative Analysis of Single-Path and Multipath Adrenal Venous Sampling in Primary Aldosteronism
Table 1
Characteristics of baseline data between single-path group and multipath group with primary aldosteronism patients receiving AVS.
Single-path AVS (SP, no. = 108)
Multipath AVS (MP, no. = 92)
value (SP vs MP)
Male
48 (44.44%)
45 (48.91%)
0.57
Age (years)
51.07 ± 12.76
50.89 ± 12.77
0.82
Height (cm)
165.96 ± 8.37
164.92 ± 8.41
0.98
Weight (kg)
68.65 ± 11.27
67.14 ± 10.61
0.51
SBP (mmHg)
157.15 ± 21.83
156.54 ± 21.54
0.98
DBP (mmHg)
92.16 ± 13.77
92.17 ± 12.81
0.42
Antihypertensive drugs
2 (1, 2)
2 (1, 2)
0.47
Cholesterol (mmol)
4.10 ± 0.80
4.10 ± 0.81
0.86
Triglyceride (mmol)
1.48 ± 0.94
1.48 ± 0.90
0.79
LDL (mmol)
2.62 ± 0.80
2.60 ± 0.78
0.82
Creatinine (μmol/L)
74.52 ± 48.81
74.45 ± 52.27
0.87
Uric acid(mmol)
358.01 ± 104.27
353.14 ± 103.85
0.91
Glycosylated hemoglobin (%)
5.63 ± 0.86
5.64 ± 0.91
0.90
Serum potassium(mmol)
3.33 ± 0.58
3.32 ± 0.56
0.87
Supine ALD (ng/dl)
20.57 (14.97, 27.40)
21.14 (15.18, 25.69)
0.89
Supine DRC (μIU/ml)
0.50 (0.20, 0.70)
0.50 (0.20, 0.62)
0.88
Supine ARR (ng/dl)
55.58 (30.54, 81.41)
56.50 (35.30, 100.00)
0.93
Upright ALD (ng/dl)
21.52 (16.29, 28.34)
21.67 (16.29, 29.12)
0.94
Uprigh DRC (μIU/ml)
0.55 (0.24, 1.06)
0.50 (0.20, 0.95)
0.82
Upright ARR (ng/dl)
35.12 (20.99, 75.59)
50.23 (26.85, 82.01)
0.48
Aldosteronoma
42 (38.89%)
38 (43.48%)
0.57
Adrenal hyperplasia
66 (61.11%)
52 (56.52%)
0.57
SBP: systolic blood pressure; DBP: diastolic blood pressure; LDL: low-density lipoprotein cholesterol; ALD: serum aldosterone; DRC: serum renin concentration; ARR: aldosterone-to-renin ratio. Age was calculated in years from birthdate to date of informed consent.
